[Federal Register Volume 61, Number 198 (Thursday, October 10, 1996)]
[Notices]
[Page 53229]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-25971]


-----------------------------------------------------------------------


DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Cancer Institute; Notice of Closed Meetings
    Pursuant to Section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C., Appendix 2), notice is hereby given of the meetings 
of the National Cancer Institute Special Emphasis Panel (SEP):

    Name of SEP: 3D Conformal Radiation Therapy.
    Date: October 15-17, 1996.
    Time: October 15--7 pm, October 16-17, 8 am.
    Place: Dumont Hotel--New York; New York, NY 10016.
    Contact Person: Dr. Gerald Lovinger, Scientific Administrator, 
National Cancer Institute, NIH, Executive Plaza North, Room 630C, 
6130 Executive Boulevard MSC 7405, Bethesda, MD 20892-7405, 
Telephone: 301/496-7987.
    Purpose/Agenda: This meeting will be devoted to the review, 
discussion, and evaluation of a grant application.
    This notice is being published less than 15 days prior to the 
above meeting due to the urgent need to meet timing limitations 
imposed by the review and funding cycle.

    Name of SEP: Oncogenes & Mitogenes--Intracellular.
    Date: October 22, 1996.
    Time: October 22--1 pm.
    Place: Teleconference, Executive Plaza North, 6130 Executive 
Boulevard, Rockville, MD 20852.
    Contact Person: Dr. Martin H. Goldrosen, Scientific Review 
Administrator, National Cancer Institute, NIH, Executive Plaza 
North, Room 635F, 6130 Executive Boulevard MSC 7405, Bethesda, MD 
20892-7405, Telephone: 301/496-7930.
    Purpose/Agenda: This meeting will be devoted to the review, 
discussion, and evaluation of a grant application.

    Name of SEP: Synthesis of Selected Chemical Carcinogens and 
Chemopreventive Agents.
    Date: October 25, 1996.
    Time: October 25--8:30 am.
    Place: 6100 Executive Boulevard, Conference Room 1, Rockville, 
MD 20852.
    Contact Person: Dr. Courtney Michael Kerwin, Scientific Review 
Administrator, National Cancer Institute, NIH, Executive Plaza 
North, Room 601, 6130 Executive Boulevard MSC 7405, Bethesda, MD 
20892-7405, Telephone: 301/496-7421.
    Purpose/Agenda: This meeting will be devoted to the review, 
discussion, and evaluation of a grant application.

    Name of SEP: Biology & Genetics of Marrow Allografts for 
Leukemia.
    Date: November 20-22, 1996.
    Time: November 20--7 pm, November 21-22, 8 am.
    Place: Loews New York, 569 Lexington Avenue, New York, NY 10022.
    Contact Person: Dr. Ray Bramhall, Scientific Review 
Administrator, National Cancer Institute, NIH, Executive Plaza 
North, Room 643, 6130 Executive Boulevard MSC 7405, Bethesda, MD 
20892-7405, Telephone: 301/496-3428.

    Purpose/Agenda: This meeting will be devoted to the review, 
discussion, and evaluation of a grant application.
    The meetings will be closed in accordance with the provisions 
set forth in secs. 552b(c)(4) and 552b(c)(6), Title 5 U.S.C. 
Applications and/or proposals and the discussions could reveal 
confidential trade secrets or commercial property such as patentable 
material and personal information concerning individuals associated 
with the applications and/or proposals, the disclosure of which 
would constitute a clearly unwarranted invasion of personal privacy.

(Catalog of Federal Domestic Assistance Program Numbers: 93.393, 
Cancer Cause and Prevention Research; 93.394, Cancer Detection and 
Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, 
Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, 
Cancer Research Manpower; 93.399, Cancer Control)

    Dated: October 3, 1996.
Paula N. Hayes,
Acting Management Officer, NIH.
[FR Doc. 96-25971 Filed 10-9-96; 8:45 am]
BILLING CODE 4140-01-M